Psychosis in Alzheimer's Disease.

Curr Neurol Neurosci Rep · 2020 · PMC7554014 · PMID 33048274

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Over the 6 months of the double-blind phase, there was a 65% highly significant reduction in relapse among participants receiving pimavanserin, with a good tolerability profile and only 1 death in the group receiving pimavanserin.

also in 132,142 other papers

a nonsignificant trendno p-value reported

Two olanzapine trials showed a nonsignificant trend towards benefit.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.